Illumina Developing Avantome Sequencing for Clinical Applications
January 26, 2010
Illumina Developing Avantome Sequencing for Clinical Applications
The company eventually plans to obtain 510(k) clearance from the US Food and Drug Administration for the platform it is developing, according to the company's president and CEO.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.